{"doi": "10.1371/journal.pone.0087444.g009", "coreId": "150718086", "oai": "oai:figshare.com:article/914507", "magId": null, "identifiers": [], "title": "NT2-D1 cells over-expressing NANOG are resistant to induction of cDDP resistance following RA pretreatment.", "authors": ["Paolo B. Abada (515065)", "Stephen B. Howell (424989)"], "enrichments": {"references": [], "citationCount": null, "documentType": {"type": null, "confidence": null}}, "contributors": [], "datePublished": "2014-01-27T03:50:01Z", "abstract": "<p>NT2-EV or NT2-NANOG cells were exposed to RA for 1 day then plated and assessed for sensitivity to cDDP 2 days after initiation of treatment by continuous drug exposure using the crystal violet staining assay. Each data point presents the mean of 3 independent experiments each performed with triplicate cultures. Vertical bars, \u00b1SEM.</p", "downloadUrl": null, "fullTextIdentifier": "https://figshare.com/articles/_NT2_D1_cells_over_expressing_NANOG_are_resistant_to_induction_of_cDDP_resistance_following_RA_pretreatment_/914507", "pdfHashValue": null, "publisher": null, "journals": [], "language": null, "relations": ["https://figshare.com/articles/_NT2_D1_cells_over_expressing_NANOG_are_resistant_to_induction_of_cDDP_resistance_following_RA_pretreatment_/914507"], "year": 2014, "topics": ["Medicine", "Drugs and devices", "Drug research and development", "oncology", "Cancer treatment", "Chemotherapy and drug treatment", "Cancers and neoplasms", "Genitourinary tract tumors", "Testicular cancer", "Basic cancer research", "Oncology agents", "urology", "cells", "over-expressing", "nanog", "resistant", "induction", "cddp", "ra"], "subjects": ["Image", "Figure"], "fullText": null, "urls": ["https://figshare.com/articles/_NT2_D1_cells_over_expressing_NANOG_are_resistant_to_induction_of_cDDP_resistance_following_RA_pretreatment_/914507"], "issn": null}